VOGLIGOLD G3 M0.3 & Voglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg.

VOGLIGOLD G3 M0.3

Voglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg

VOGLIGOLD G3 M0.3 is an advanced oral antidiabetic medication designed to manage type 2 diabetes mellitus effectively. This combination drug contains three active ingredients: Glimepiride, Metformin, and Voglibose. Each component plays a vital role in controlling blood sugar levels, making Voglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg a comprehensive solution for diabetes management. It helps patients achieve better glycemic control, reduce the risk of diabetes-related complications, and improve their overall quality of life.

Key Ingredients and Their Benefits

Glimepiride

• Mechanism of Action: Glimepiride is a sulfonylurea that stimulates the release of insulin from pancreatic beta cells. It enhances insulin sensitivity and improves glucose uptake by tissues.
• Benefits: Effective in lowering blood sugar levels, reducing fasting and postprandial glucose, and improving HbA1c levels. It helps in the efficient management of type 2 diabetes.

Metformin

• Mechanism of Action: Metformin is a biguanide that decreases hepatic glucose production, reduces intestinal glucose absorption, and enhances insulin sensitivity in peripheral tissues.
• Benefits: Known for its effectiveness in lowering blood sugar levels, promoting weight loss, and reducing cardiovascular risks associated with diabetes. It helps maintain stable blood sugar levels throughout the day.

Voglibose

• Mechanism of Action: Voglibose is an alpha-glucosidase inhibitor that delays the absorption of carbohydrates from the intestine, leading to a gradual rise in blood sugar levels after meals.
• Benefits: Reduces postprandial hyperglycemia, improves overall glycemic control, and minimizes the risk of diabetes-related complications.

How VOGLIGOLD G3 M0.3 Works

Synergistic Effect of the Combination

VOGLIGOLD G3 M0.3 combines the benefits of Glimepiride, Metformin, and Voglibose to provide a multi-faceted approach to diabetes management. Each ingredient targets different aspects of glucose metabolism:

• Glimepiride: Increases insulin secretion from the pancreas, helping to lower blood sugar levels.
• Metformin: Reduces hepatic glucose production and enhances insulin sensitivity, stabilizing blood sugar levels.
• Voglibose: Delays carbohydrate absorption, preventing post-meal spikes in blood sugar.

Comprehensive Blood Sugar Control

The combination of these three agents ensures comprehensive blood sugar control by addressing multiple pathways of glucose regulation. This multi-pronged approach helps in achieving target blood glucose levels, reducing HbA1c, and minimizing the risk of hypoglycemia.

Benefits of VOGLIGOLD G3 M0.3

Improved Glycemic Control

• Effective Blood Sugar Reduction: VOGLIGOLD G3 M0.3 helps lower both fasting and postprandial blood sugar levels, providing better overall glycemic control.
• Stable HbA1c Levels: Regular use of this medication helps maintain stable HbA1c levels, which is a crucial marker of long-term glucose control.

Reduced Risk of Complications

• Prevents Cardiovascular Risks: By managing blood sugar levels effectively, VOGLIGOLD G3 M0.3 reduces the risk of cardiovascular complications commonly associated with diabetes.
• Minimizes Diabetes-Related Complications: Helps prevent complications such as neuropathy, nephropathy, and retinopathy by maintaining optimal blood sugar levels.

Enhanced Quality of Life

• Weight Management: Metformin in VOGLIGOLD G3 M0.3 aids in weight loss and prevents weight gain, which is beneficial for diabetes patients.
• Convenient Dosage: Combines three effective antidiabetic agents in a single tablet, simplifying the treatment regimen and improving patient compliance.

Usage and Dosage

Recommended Dosage

The recommended dosage of VOGLIGOLD G3 M0.3 should be determined by a healthcare provider based on individual patient needs, blood sugar levels, and overall health condition. It is typically taken once or twice daily with meals to enhance absorption and minimize gastrointestinal side effects.

Administration

• With Meals: Taking VOGLIGOLD G3 M0.3 with meals helps improve drug efficacy and reduce gastrointestinal discomfort.
• Consistency: For optimal results, take the medication consistently at the same time each day as prescribed by your healthcare provider.

Safety and Side Effects

Safety Precautions

• Medical History: Inform your healthcare provider about your complete medical history, including any liver, kidney, or heart conditions, before starting VOGLIGOLD G3 M0.3.
• Drug Interactions: Be aware of potential interactions with other medications, including other antidiabetic drugs, diuretics, corticosteroids, and certain blood pressure medications.

Potential Side Effects

While VOGLIGOLD G3 M0.3 is generally well-tolerated, some individuals may experience mild to moderate side effects, including:

• Hypoglycemia: Low blood sugar levels, which may cause symptoms such as dizziness, sweating, and confusion.
• Gastrointestinal Issues: Nausea, diarrhea, abdominal pain, and bloating.
• Allergic Reactions: Rash, itching, or swelling. Seek immediate medical attention if you experience any severe allergic reactions.

Who Can Benefit from VOGLIGOLD G3 M0.3?

Individuals with Type 2 Diabetes

• Uncontrolled Diabetes: Patients with type 2 diabetes who have not achieved adequate glycemic control with diet, exercise, and monotherapy.
• At Risk of Complications: Those at higher risk of developing diabetes-related complications such as cardiovascular disease, neuropathy, and nephropathy.

Those Seeking Comprehensive Diabetes Management

• Multi-Pronged Approach: Individuals looking for a medication that addresses multiple pathways of glucose regulation for better overall diabetes management.
• Simplified Treatment Regimen: Patients who prefer a single tablet that combines the benefits of three effective antidiabetic agents.

Conclusion

VOGLIGOLD G3 M0.3 is a powerful combination medication designed to manage type 2 diabetes effectively. By integrating the benefits of Glimepiride, Metformin, and Voglibose, it offers a comprehensive approach to glycemic control, reduces the risk of diabetes-related complications, and improves the overall quality of life for patients. Always consult with your healthcare provider to determine the appropriate dosage and to ensure that VOGLIGOLD G3 M0.3 is the right choice for your diabetes management plan.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW